返回
Infant Bacterial Therapeutics AB (publ)（IFTBF）价格
IFTBF 股价走势图
IFTBF 财务
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
截至今日：Jan 27, 14:55:08 GMT-5
收入
资产负债表
现金流量
年度
季度性
IFTBF 收入
以百万美元为单位的财务数据。财年为2月至次年1月。
Follow-Up Questions
Infant Bacterial Therapeutics AB (publ) 的关键财务报表是什么？
IFTBF 的关键财务比率是什么？
Infant Bacterial Therapeutics AB (publ) 的收入按细分市场或地理位置如何划分？
Infant Bacterial Therapeutics AB (publ) 是否盈利？
Infant Bacterial Therapeutics AB (publ) 有负债吗？
Infant Bacterial Therapeutics AB (publ) 的流通股有多少？
关键数据
前收盘价
$4.78
开盘价
$5.47
当日区间
$5.47 - $5.47
52周范围
$4.78 - $8.2
交易量
--
平均成交量
1.0K
每股收益（TTM）
--
股息收益率
--
市值
$71.2M
什么是 INFANT BACTERIAL THERAPEUTICS A？
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.